Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease

BACKGROUND: Existing therapies for recurrent or refractory histiocytoses, including Langerhans cell histiocytosis (LCH), juvenile xanthogranuloma (JXG), and Rosai-Dorfman disease (RDD), have limited effectiveness. We report our experience with using clofarabine as therapy in children with recurrent...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pediatr Blood Cancer
Autors principals: Simko, Stephen J., Tran, Huy D., Jones, Jeremy, Bilgi, Mrinalini, Beaupin, Lynda Kwon, Coulter, Don, Garrington, Timothy, McCavit, Timothy L., Moore, Colin, Rivera-Ortegón, Francisco, Shaffer, Linda, Stork, Linda, Turcotte, Lucie, Welsh, Esperanza C., Hicks, M. John, McClain, Kenneth L., Allen, Carl E.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4474604/
https://ncbi.nlm.nih.gov/pubmed/24106153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24772
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars